Pitfalls in pushing fistulas ----

Similar documents
2006 NKF-DOQI Guidelines Preferred Vascular Access Order 1. Radiocephalic (wrist) fistula 2. Brachiocephalic (elbow) fistula 3. Basilic vein transposi

UC SF. End Stage Renal Disease. National Kidney Foundation Dialysis Outcomes Quality Initiative (K/DOQI) BUT-- No Cephalic Vein What s Next

Introduction to the Native Arteriovenous Fistula: A primer for medical students and radiology residents

A Vascular Access Report for the Year 2009 Access planning, execution and maintenance!!

Measure #330: Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days National Quality Strategy Domain: Patient Safety

Sid Bhende MD Sentara Vascular Specialists April 28 th Dialysis Access Review: Understanding the Access Options our Patients Face

Measure #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

CATHETER REDUCTION. Angelo N. Makris, M.D. Medical Director Chicago Access Care

Quality ID #329: Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis National Quality Strategy Domain: Effective Clinical Care

Selection of Permanent Hemodialysis Vascular Access

Steal Syndrome: The Role of the Vascular Lab

Vascular Access creation in the US A surgical perspective. Surendra Shenoy M.D., Ph.D. Section of Transplantation Department of Surgery

PREVENTION AND TREATMENT OF ANEURYSMS OF AUTOGENOUS DIALYSIS ACCESSES STEPHEN L. HILL, M.D.,F.A.C.S

Int J Adv Med. For your questions please send message to

Superficialización de la vena basílica. Pierre BOURQUELOT, Paris

NKF K/DOQI GUIDELINES

HD Scanning: Velocities and Volume Flow

Case #1. Case #1- Possible codes. Unraveling the -59 modifier. Principles of Interventional. CASE 1: Simple angioplasty

ASDIN 8th Annual Scientific Meeting

Jimmy Wei Hwa Tan, Surg, MD

What s on the Horizon in Dialysis Access? Libby Watch, MD, FACS Miami Cardiac & Vascular Institute

Medical Director/Surgeon as Partners WebEx February 11, 2010

Why Can't I Cannulate This Fistula? Fistula Immaturity: The Simple But Critical Steps for a Functioning (Mature) AVF

Bare Metal Stents vs Stent Grafts

Percutaneous AV Fistula Creation. Ellipsys EndoAVF System

KDOQI Guidelines. Overview. Predicting Successful Fistula Maturation Warren Gasper MD UCSF Vascular Surgery Fellow 2011 UCSF Vascular Symposium

Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access

The HeRO Graft. Shawn M. Gage, PA Division of Vascular Surgery Duke University Medical Center

Victoria Chapman BS, RN, HP (ASCP)

Upper Extremity Venous Duplex. Michigan Sonographers Society Fall Ultrasound Symposium October 15, 2016

Evaluation of AVF and AVG

Puncture Ultrasound Guidance: Decrease Access Site Complications. Peter A. Schneider, MD Kaiser Foundation Hospital Honolulu, Hawaii

AV Access Technology and Innovation DEVICES CHANGING HOW WE THINK ABOUT VASCULAR ACCESS

Preservation of Veins and Timing for Vascular Access

Access Preservation: Recurrent Central Venous Stenosis, Pacemaker Wires and other Nightmares. Who am I? Disclosures

Dialysis Overview S J Fratesi MD FRCS

Vascular Access for Haemodialysis. Mike Stephens

IN ARTERIOVENOUS FISTULA FAILURE

AV ACESS COMPLICATIONS. Ass. Prof. Dr. Habas

UPDATE IN VASCULAR ACCESS Mercedeh Kiaii MD FRCPC Rick Luscombe RN BSN CNeph(C) Elizabeth Lee MD FRCPC

Anesthetic Options for Patients Undergoing Dialysis Access Procedures Derek T. Woodrum, M.D. University of Michigan Hospitals, Ann Arbor, MI

Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance

Conversion of tunneled hemodialysis catheter consigned patients to arteriovenous fistula

LUTONIX AV Clinical Trial

Regardless of whether you are a vascular surgeon,

Sonographic Evaluation of an Immature Brescia-Cimino Fistula

Chapter 2 Proximal Forearm Arteriovenous Fistula Creation

Schedule of Benefits. for Professional Fees Vascular Procedures

Thrombectomy, open, arteriovenous fistula without revision, autogenous or nonautogenous dialysis graft (separate procedure)

Autogeneous Elbow Fistulas: the Effect of Diabetes mellitus on Maturation, Patency, and Complication Rates

Division of Vascular Surgery and Endovascular Therapy, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX - USA

AVF Prevalence. Local elastase to aid fistula maturation. I have nothing to disclose

A New Technique to Superficialize Arteriovenous Fistulas Too Deep for Reliable Cannulation

Dr. Murty Mantha MD FRACP Cairns Base Hospital Cairns. DNT 2011 Hunter Valley

Morbidity Audit and Logbook Tool SNOMED Board Reporting Terms for SET and IMG Vascular Surgery AMPUTATION AORTA

Supera for the Juxta-anastomotic AVF Stenosis

Vascular Access Care Plans: How Can a Care Plan Really Improve Care and Make Everyone s Job Easier?

Cephalic Arch Stenosis: A unique entity

ASDIN 7th Annual Scientific Meeting DISCLOSURES TECHNICAL CONSIDERATIONS TECHNICAL CONSIDERATIONS UTILITY OF ULTRASOUND IN EVALUATING ACCESS


Ultrasound and the dialysis patient

Evaluation of the efficacy of the forearm basilic vein transposition arteriovenous fistula

Technical and Clinical Barriers to Implementing an Optimal Case Mix of Vascular Access

First experience with DCB for treatment of dialysis access stenosis The Greek experience

PEER MENTORSHIP TRAINING PROGRAM ESRD National Coordinating Center (NCC)

III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000

What vascular access for which patient : obesity

Vascular a ccess access for Dialysis a surgeon s perspecti e v. some observations

Recurrent lesions in AV access & Initial DCB experience in India

Vascular Access Options for Apheresis Medicine

Physician s Vascular Interpretation Examination Content Outline

Hemodialysis Fistula Maturation Consortium

Outcome after autogenous brachial-basilic upper arm transpositions in the post-national Kidney Foundation Dialysis Outcomes Quality Initiative era

COVERA covered stent to treat stenosis in arteriovenous fistula: 6-month results from the prospective, multi-center, randomized AVeNEW study

Changes in the practice of angioaccess surgery: Impact of dialysis outcome and quality initiative recommendations

Prospective, randomized controlled study of paclitaxel-coated versus plain balloon angioplasty for the treatment of failing dialysis access

ASDIN 9th Annual Scientific Meeting

The Art of Angioplasty

End Stage Renal Disease (ESRD) Network Learning and Action Network (LAN) Series: Bloodstream Infection (BSI) Quality Improvement Activity

Renal Physicians Association Kidney Quality Improvement Registry, Powered by Premier, Inc non-mips Measure Specifications

Vascular Surgery and Transplant Unit University of Catania. Pierfrancesco Veroux

Postoperative AV Fistula Evaluation. Postoperative examination protocol. Postoperative AVF Protocol. Hemodialysis Access Surveillance

Lutonix in AV fistula and Early look AV IDE trial data

Disclosure. Speaker name: Prof. Hesham Aly Sharaf El-Din. I do not have any potential conflict of interest

Haemodialysis access with an arteriovenous fistula

THE VESSELS OF BLOOD CIRCULATION

IN.PACT AV Access IDE Study Full Baseline Data. Robert Lookstein, MD MHCDL New York, NY On Behalf of the IN.PACT AV ACCESS Investigators

Brachial vein transposition arteriovenous fistulas for hemodialysis access

COVERA Vascular Covered Stents in the Management of Dysfunctional AV Access

Early adopters and clinical investigators of percutaneous. The SIR 2016 Panel on Endovascular Arteriovenous Fistula Creation

Arterial Access for Diagnosis and Intervention T-Woei Tan, MD, FACS

It is important to learn all you can about your access so you can take better care of yourself.

ORIGINAL ARTICLE. Outcomes of Upper Arm Arteriovenous Fistulas for Maintenance Hemodialysis Access

Cardiovascular Implantable Electronic Device Leads & Arteriovenous Hemodialysis Access

Ultrasound as a Tool for Preoperative Planning, Monitoring, and Interventions in Dialysis Arteriovenous Access

Review Article Duplex Ultrasound Evaluation of Hemodialysis Access: A Detailed Protocol

PROGRAM. Embassy Suites Hotel Kennesaw Town Center

COVERA Vascular Covered Stents Innovation in AV Access

Cost Analysis of the Creation and Maintenance of Functional Arteriovenous Grafts for Hemodialysis

Clinical hemodialysis experience with percutaneous arteriovenous fistulas created using the Ellipsys vascular access system

Transcription:

Pitfalls in pushing fistulas ---- An argument for more grafts Marc Webb, MD, FACS Michigan Vascular Access, PC March 27 th, 2009

Vascular Access for Hemodialysis ------- Basic facts - the need for Access Hemodialysis is a life-sustaining treatment that must be provided on a regular basis Vascular access is essential for the provision of dialysis - no blood flow, no hemodialysis Disruptive and life-threatening loss of access occurs frequently in the dialysis population Problems with dialysis access is the leading cause of morbidity and dissatisfaction

Vascular Access for Hemodialysis ------- Basic facts - new patients 96,000 new patients are added each year Half of new patients will need a catheter to initiate dialysis and then get their permanent access placement 10% of grafts and 30% of fistulas require secondary procedures prior to usability Vascular access is responsible for 25-30% of ESRD costs - $1.5 billion dollars in 1998 (!!!)

The National Kidney Foundation Dialysis Outcomes Quality Initiative (DOQI 1997) Created a framework of evidence-based guidelines and benchmarks to clarify best-practices in the provision of Vascular Access

The DOQI three key points toward better care Avoiding central catheterization, thus avoiding loss of central patency Maintenance of existing access by detecting impending failure and prompt intervention Maximizing creation of fistulas as the best long-term access

NVAII The National Vascular Access Improvement Initiative Mission Statement (1) To increase the likelihood that every eligible patient will receive the most optimal form of vascular access (in the majority of cases an AV fistula); and (2) that vascular access complications will be avoided through appropriate access monitoring and intervention

The traditional case for superiority of fistulas Relatively minor tissue trauma Best long term patency (80% @ 1 yr) Tolerates low blood pressure (systolic BP <100 mm Hg) Low infection rate (< 1%/yr) Low incidence of Steal Syndrome (<2%)

The problem with fistulas Greater rate of primary failure with fistulas 50-60% maturation of fistulas being reported recently Reports of increased prevalence of catheters and prolonged duration of catheterization More maintenance and maturation procedures are being required More and more tissue trauma required with advanced fistulas (superficialization/transposition) More central venous damage due to prolonged catheterization

Central venous stenosis The sad consequence of catheters left in too long

Stented subclavian

Ten month follow-up - the fourth reintervention

Delays and problems in creating fistulas

Problems in achieving functional fistulas on the venous side Most people have vessels that are intrinsically small and have to grow This process of growing the veins takes weeks or months and sometimes they just don t grow Venous depletion or injury due to IV catheters and PICC lines can preclude or doom the process Depletion of veins due to previous accesses Central venous stenosis due to prolonged catheterization, pacemaker or AICDs

Venous variation at the elbow

Clot in basilic vein

Problems in achieving functional fistulas on the arterial side Intrinsically small arteries small stature, female gender Congenital variation - high bifurcation Vascular disease diabetes, lupus, systemic atherosclerosis Deficits due to previous accesses

Arteries at the elbow Normal and variant high bifurcation

Ultrasound examination of brachial artery (high bifurcation)

High bifurcation of the brachial artery

Brachial artery disease

Outcome - 150 fistulas in the obese maturation rates type total released usable pend fail/sac lost/exp AVF, wrist 21 17 81% 0 2 2 AVF, forearm 13 9 69% 0 2 2 AVF, brachiocephalic 27 20 74% 0 5 2 simple fistulas - total 61 46 75% 0 9 6 brachiocephalic by transposition 6 5 83% 0 1 0 brachiocephalic, superficialized 39 33 85% 4 2 0 one stage BVT 16 15 94% 0 1 0 two stage BVT 28 21 75% 2 2 3 complex fistulas - total 89 74 83% 6 6 3 overall totals 150 120 80% 6 15 9

Outcome - 90 fistulas in the elderly maturation rates type overall released %usable pending fail/sac lost/exp AVF, wrist 5 3 60% 1 1 0 AVF, forearm 11 8 73% 0 2 1 AVF, brachiocephalic 36 32 89% 0 2 2 simple fistulas - total 52 43 83% 1 5 3 brachiocephalic by transposition 2 1 50% 0 0 1 brachiocephalic, superficialized 4 3 75% 1 0 0 one stage BVT 14 11 79% 0 3 0 two stage BVT 18 13 72% 1 1 3 complex fistulas - total 38 28 74% 2 4 4 totals 90 71 79% 3 9 7

The elderly with and without complex fistulas catheter simple complex graft catheter simple complex graft 61% fistulas 37% fistulas

Complex fistulas Superficialized and transposed fistulas Are they wonderful or not?

Transposed Brachial-Basilic Fistula

Completed Transposed Basilic Fistula

Superficialization of existing fistula

Superficialization before and after

Superficialization of existing fistula

Superficialization of existing fistula

Superficialization of existing fistula

Repairing ring in fistula

Repaired ring of fistula

Branch venoplasty of fistula

Branch venoplasty of fistula

Percutaneous venoplasty of fistula stenosis

Percutaneous venoplasty of fistula stenosis

Percutaneous venoplasty of fistula stenosis

Percutaneous venoplasty of fistula stenosis

Time to release of transposed basilic fistulas versus Artegrafts BVT above previous access (37) 37.2 days BVT one-stage naïve (62) 51.4 days BVT two-stage (110) 123 days Artegrafts (60) 28.15 days

The argument for a graft in selected patients Lower failure rate, more predictable results Earlier availability leading to shorter central venous catheterization, and thus: Lower risk of central venous stenosis Eliminate need for maturation procedures Less tissue trauma than transposed fistulas More versatile in configuration

Forearm loop graft

Arm graft

Arm loop graft

Venaflo with Carbon eptfe

Almost a fistula - the Procol bovine mesenteric vein prosthesis

The Artegraft

Conclusions Central stenosis Central venous stenosis is the most common, most serious and most ignored limiting factor in dialysis Loss of central patency can be fatal Reducing duration of central venous catheterization and preventing loss of central patency is the most important goal, not what type of material is used for the conduit

Conclusions Graft versus fistula A good fistula is better than a good graft A good graft is better than a bad fistula Patients not yet on dialysis can afford a long development phase - patients with a central catheter cannot afford to keep it too long Surgeons should be more aware of the passage of time, and should be more willing to use a graft to get the catheters out in time

Conclusions Graft materials Shifting the paradigm back toward grafts is aided by the development and promotion of better techniques, and better graft materials Less thrombogenic, less infection prone, and more biologically compatible grafts may be the answer we need For the last six months I have been using the Artegraft for all of my grafts and questioning my dialysis access algorithms re fistulas.

I am Marc Webb, and I approve this message

The End